logo

1.01

1.01 (-6.74%)

As of Mar 06, 2024

Sangamo Therapeutics, Inc [SGMO]

Source: 

Company Overview

We are a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious diseases. We plan to deliver on this mission through development of our clinical and preclinical product candidates leveraging our novel science and our in-house manufacturing capabilities.

CountryUnited States
Headquartersbrisbanecalifornia
Phone Number5109706000
Industry
manufacturing
CEOAlexander D. Macrae
Websitewww.sangamo.com